TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Djurfarmacia Sverige AB
Closing information (x1000 EUR)
| Closing information | 2024/08 | 2023/08 | 2022/08 |
| Turnover |
41,109
|
35,383
|
33,776 |
| Financial expenses |
3
|
24
|
4 |
| Earnings before taxes |
2,188
|
1,677
|
1,958 |
| EBITDA |
2,443
|
1,939
|
2,040 |
| Total assets |
10,500
|
9,214
|
9,640 |
| Current assets |
8,431
|
7,167
|
7,411 |
| Current liabilities |
4,329
|
4,140
|
4,204 |
| Equity capital |
5,731
|
4,681
|
4,659 |
| - share capital |
9
|
8
|
9 |
| Employees (average) |
44
|
53
|
47 |
Financial ratios
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Solvency |
54.6%
|
50.8%
|
48.3% |
| Turnover per employee |
934
|
668
|
719 |
| Profit as a percentage of turnover |
5.3%
|
4.7%
|
5.8% |
| Return on assets (ROA) |
20.9%
|
18.5%
|
20.4% |
| Current ratio |
194.8%
|
173.1%
|
176.3% |
| Return on equity (ROE) |
38.2%
|
35.8%
|
42.0% |
| Change turnover |
4,141
|
4,918
|
3,049 |
| Change turnover % |
11%
|
16%
|
10% |
| Chg. No. of employees |
-9
|
6
|
5 |
| Chg. No. of employees % |
-17%
|
13%
|
12% |
Total value of public sale
| Fiscal year | 2024/08 | 2023/08 | 2022/08 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.